Use of AI in the NHS is leading to a 30-times improvement in early cancer detection rates

Nov 20, 2020

Cancer may be the world’s second largest killer, but there is lots of innovative work going on in the realm of AI software to improve early diagnosis and, therefore, boost survival rates. Two companies doing just that are UK-based C the Signs and Panakeia Technologies. See more

Panakeia to present results of blinded multi-site validation of its AI-driven molecular profiling tool for colon cancer, PANProfiler Colon, at ASCO GI Symposium

Panakeia launches PANProfiler Colon, an AI-driven tool for precision medicine in colon cancer

PANProfiler Colon determines MSI/dMMR status in minutes from colon cancer tissue samples Entirely digital, AI-driven molecular profiling...

Panakeia to attend and present at upcoming scientific and business conferences

Use of AI in the NHS is leading to a 30-times improvement in early cancer detection rates

Comments